Urinary podocalyxin, the novel biomarker for detecting early renal change in obesity

Journal of Nephrology

Volumn 29, Issue 1, 2016, Pages 37-44

  Suwanpen, Chayanut ^a   Nouanthong, Phonethipsavanh ^b   Jaruvongvanich, Veeravich ^c   Pongpirul, Krit ^a,d   Pongpirul, Wannarat Amornnimit ^a   Leelahavanichkul, Asada ^a   Kanjanabuch, Talerngsak ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b Pasteur Institute du Laos   (Laos)

^c UNIVERSITY OF HAWAII   (United States)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Metabolic syndrome; Obesity; Podocalyxin; Podocyte; Proteinuria

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; PODOCALYXIN; VASCULOTROPIN; BIOLOGICAL MARKER; CREATININE; SIALOGLYCOPROTEIN;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EXCRETION; FEMALE; FLOW CYTOMETRY; GLOMERULUS FILTRATION RATE; HUMAN; MALE; OBESITY; PROTEINURIA; RENAL SYSTEM PARAMETERS; URINE PROTEIN CREATININE RATIO; CASE CONTROL STUDY; COMPLICATION; CYTOLOGY; EARLY DIAGNOSIS; KIDNEY DISEASES; METABOLISM; PATHOPHYSIOLOGY; PODOCYTE; PREDICTIVE VALUE; URINALYSIS; URINE;

BIOMARKERS; BODY MASS INDEX; CASE-CONTROL STUDIES; CREATININE; EARLY DIAGNOSIS; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; OBESITY; PODOCYTES; PREDICTIVE VALUE OF TESTS; PROTEINURIA; SIALOGLYCOPROTEINS; URINALYSIS; URINE;

EID: 84961351073     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.1007/s40620-015-0199-8     Document Type: Article

References (33)

1. Drumond MC, Deen WM (1994) Structural determinants of glomerular hydraulic permeability. Am J Physiol 266:F1–F12
2. Kriz W (2002) Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 57:189–195
3. Shankland SJ, Pippin JW, Duffield JS (2014) Progenitor cells and podocyte regeneration. Semin Nephrol 34:418–428
4. Petermann A, Floege J (2007) Podocyte damage resulting in podocyturia: a potential diagnostic marker to assess glomerular disease activity. Nephron Clin Pract 106:c61–c66
5. Vogelmann SU, Nelson WJ, Myers BD, Lemley KV (2003) Urinary excretion of viable podocytes in health and renal disease. Am J Physiol Ren Physiol 285:F40–F48
6. Doyonnas R, Kershaw DB, Duhme C, Merkens H, Chelliah S, Graf T et al (2001) Anuria, omphalocele, and perinatal lethality in mice lacking the CD34-related protein podocalyxin. J Exp Med 194:13–27
7. Skoberne A, Konieczny A, Schiffer M (2009) Glomerular epithelial cells in the urine: what has to be done to make them worthwhile? Am J Physiol Ren Physiol 296:F230–F241
8. Barisoni L, Kriz W, Mundel P, D’Agati V (1999) The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 10:51–61
9. Hara M, Yanagihara T, Takada T, Itoh M, Matsuno M, Yamamoto T et al (1998) Urinary excretion of podocytes reflects disease activity in children with glomerulonephritis. Am J Nephrol 18:35–41
10. Hara M, Yanagihara T, Kihara I (2001) Urinary podocytes in primary focal segmental glomerulosclerosis. Nephron 89:342–347
11. Achenbach J, Mengel M, Tossidou I, Peters I, Park JK, Haubitz M et al (2008) Parietal epithelia cells in the urine as a marker of disease activity in glomerular diseases. Nephrol Dial Transpl 23:3138–3145
12. Hara M, Yanagihara T, Kihara I (2007) Cumulative excretion of urinary podocytes reflects disease progression in IgA nephropathy and Schonlein-Henoch purpura nephritis. Clin J Am Soc Nephrol 2:231–238
13. World Health Organization (2014) Obesity and overweight
14. Snyder S, Turner GA, Turner A (2014) Obesity-related kidney disease. Prim Care 41:875–893
15. Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498–1509
16. Darouich S, Goucha R, Jaafoura MH, Zekri S, Ben Maiz H, Kheder A (2011) Clinicopathological characteristics of obesity-associated focal segmental glomerulosclerosis. Ultrastruct Pathol 35:176–182
17. Ziyadeh FN, Wolf G (2008) Pathogenesis of the podocytopathy and proteinuria in diabetic glomerulopathy. Curr Diabetes Rev 4:39–45
18. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3:349–363
19. Muchaneta-Kubara EC, el Nahas AM (1997) Myofibroblast phenotypes expression in experimental renal scarring. Nephrol Dial Transpl 12:904–915
20. Weisell RC (2002) Body mass index as an indicator of obesity. Asia Pacific J Clin Nutr 11(Suppl 8):S681–S684
21. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW et al (2007) Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem 53:766–772
22. Schwab SJ, Christensen RL, Dougherty K, Klahr S (1987) Quantitation of proteinuria by the use of protein-to-creatinine ratios in single urine samples. Arch Intern Med 147:943–944
23. Kanno K, Kawachi H, Uchida Y, Hara M, Shimizu F, Uchiyama M (2003) Urinary sediment podocalyxin in children with glomerular diseases. Nephron Clin Pract 95:c91–c99
24. Ye H, Bai X, Gao H, Li L, Wu C, Sun X et al (2014) Urinary podocalyxin positive-element occurs in the early stage of diabetic nephropathy and is correlated with a clinical diagnosis of diabetic nephropathy. J Diabetes Complicat 28:96–100
25. Akakabe Y, Koide M, Kitamura Y, Matsuo K, Ueyama T, Matoba S et al (2013) Ecscr regulates insulin sensitivity and predisposition to obesity by modulating endothelial cell functions. Nat Commun 4:2389
26. Barton M, Baretella O, Meyer MR (2012) Obesity and risk of vascular disease: importance of endothelium-dependent vasoconstriction. Br J Pharmacol 165:591–602
27. Ritz E, Koleganova N, Piecha G (2011) Is there an obesity-metabolic syndrome related glomerulopathy? Curr Opin Nephrol Hypertens 20:44–49
28. Ritz E (2008) Metabolic syndrome and kidney disease. Blood Purif 26:59–62
29. Shen WW, Chen HM, Chen H, Xu F, Li LS, Liu ZH (2010) Obesity-related glomerulopathy: body mass index and proteinuria. Clin J Am Soc Nephrol 5:1401–1409
30. Camici M (2008) Urinary biomarkers of podocyte injury. Biomark Med 2:613–616
31. Zhu B, Li XF, Zhu XL, Lin Y, Zhong S, Zhu CF et al (2014) ELISA analysis of urinary nephrin and podocalyxin standardized by aquaporin-2 in adult patients with nephrotic syndrome. J Nephrol 27:411–417
32. Habara P, Mareckova H, Sopkova Z, Malickova K, Zivorova D, Zima T et al (2008) A novel method for the estimation of podocyte injury: podocalyxin-positive elements in urine. Folia Biol 54:162–167
33. Habara P, Mareckova H, Malickova K, Potysova Z, Hruskova Z, Zima T et al (2012) Novel flow cytometric method for the detection of podocalyxin-positive elements in urine of patients with glomerulonephritides—first promising results. Folia Biol 58:57–63